 |
The Journal of Neuroscience, March 17, 2004, 24(11):2667-2677; doi:10.1523/JNEUROSCI.5377-03.2004
Previous Article | Next Article 
Cellular/Molecular
Electroconvulsive Seizures Regulate Gene Expression of Distinct Neurotrophic Signaling Pathways
C. Anthony Altar,
Pascal Laeng,
Linda W. Jurata,
Jeffrey A. Brockman,
Andrew Lemire,
Jeffrey Bullard,
Yury V. Bukhman,
Theresa A. Young,
Vinod Charles, and
Michael G. Palfreyman
Psychiatric Genomics, Gaithersburg, Maryland 20878
Electroconvulsive therapy (ECT) remains the treatment of choice for drug-resistant patients with depressive disorders, yet the mechanism for its efficacy remains unknown. Gene transcription changes were measured in the frontal cortex and hippocampus of rats subjected to sham seizures or to 1 or 10 electroconvulsive seizures (ECS), a model of ECT. Among the 35004400 RNA sequences detected in each sample, ECS increased by 1.5- to 11-fold or decreased by at least 34% the expression of 120 unique genes. The hippocampus produced more than three times the number of gene changes seen in the cortex, and many hippocampal gene changes persisted with chronic ECS, unlike in the cortex. Among the 120 genes, 77 have not been reported in previous studies of ECS or seizure responses, and 39 were confirmed among 59 studied by quantitative real time PCR. Another 19 genes, 10 previously unreported, changed by <1.5-fold but with very high significance. Multiple genes were identified within distinct pathways, including the BDNFMAP kinasecAMPcAMP response element-binding protein pathway (15 genes), the arachidonic acid pathway (5 genes), and more than 10 genes in each of the immediate-early gene, neurogenesis, and exercise response gene groups. Neurogenesis, neurite outgrowth, and neuronal plasticity associated with BDNF, glutamate, and cAMPprotein kinase A signaling pathways may mediate the antidepressant effects of ECT in humans. These genes, and others that increase only with chronic ECS such as neuropeptide Y and thyrotropin-releasing hormone, may provide novel ways to select drugs for the treatment of depression and mimic the rapid effectiveness of ECT.
Key words: hippocampus; frontal cortex; ECS; microarray; gene expression; depression; bipolar disorder
Received June 10, 2003;
revised January 15, 2004;
accepted January 16, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
S. Loebrich and E. Nedivi
The Function of Activity-Regulated Genes in the Nervous System
Physiol Rev,
October 1, 2009;
89(4):
1079 - 1103.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ruiz de Almodovar, D. Lambrechts, M. Mazzone, and P. Carmeliet
Role and Therapeutic Potential of VEGF in the Nervous System
Physiol Rev,
April 1, 2009;
89(2):
607 - 648.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. V. Lund, Y. Hu, Y. H. Raol, R. S. Benham, R. Faris, S. J. Russek, and A. R. Brooks-Kayal
BDNF Selectively Regulates GABAA Receptor Transcription by Activation of the JAK/STAT Pathway
Sci. Signal.,
October 14, 2008;
1(41):
ra9 - ra9.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ueta, R. Yamamoto, S. Sugiura, K. Inokuchi, and N. Kato
Homer 1a Suppresses Neocortex Long-Term Depression in a Cortical Layer-Specific Manner
J Neurophysiol,
February 1, 2008;
99(2):
950 - 957.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Thakker-Varia, J. J. Krol, J. Nettleton, P. M. Bilimoria, D. A. Bangasser, T. J. Shors, I. B. Black, and J. Alder
The Neuropeptide VGF Produces Antidepressant-Like Behavioral Effects and Enhances Proliferation in the Hippocampus
J. Neurosci.,
November 7, 2007;
27(45):
12156 - 12167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kedmi and A. Orr-Urtreger
Expression changes in mouse brains following nicotine-induced seizures: the modulation of transcription factor networks
Physiol Genomics,
August 20, 2007;
30(3):
242 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Medina
Extrasynaptic NMDA Receptors Reshape Gene Ranks
Sci. Signal.,
May 15, 2007;
2007(386):
pe23 - pe23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Park, R. Gong, J. Stuart, and S.-J. Tang
Molecular Network and Chromosomal Clustering of Genes Involved in Synaptic Plasticity in the Hippocampus
J. Biol. Chem.,
October 6, 2006;
281(40):
30195 - 30211.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. Pieper, X. Wu, T. W. Han, S. J. Estill, Q. Dang, L. C. Wu, S. Reece-Fincanon, C. A. Dudley, J. A. Richardson, D. J. Brat, et al.
The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice
PNAS,
September 27, 2005;
102(39):
14052 - 14057.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. R. Albert and S. Lemonde
5-HT1A Receptors, Gene Repression, and Depression: Guilt by Association
Neuroscientist,
December 1, 2004;
10(6):
575 - 593.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hao, T. Creson, L. Zhang, P. Li, F. Du, P. Yuan, T. D. Gould, H. K. Manji, and G. Chen
Mood Stabilizer Valproate Promotes ERK Pathway-Dependent Cortical Neuronal Growth and Neurogenesis
J. Neurosci.,
July 21, 2004;
24(29):
6590 - 6599.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|